Remove Drug Development Remove Health IT Remove Life Science Remove Strategy
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis.

article thumbnail

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

Healthcare IT Today

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prognos Health Raises $23 Million

Healthcare IT Today

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

article thumbnail

Like banks, healthcare will become digital-first in 2022, Zoom healthcare lead says

Healthcare IT News - Telehealth

Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. You predict that decentralization will become a major theme for health and life science organizations. Please elaborate.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

Mountain Group Partners’ investment strategy has always focused squarely on supporting companies like AngelEye Heath that are developing transformational technologies that improve the lives of others,” said Byron Smith , Managing Director at Mountain Group Partners. About Mountain Group Partners. About SeedtoB.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. QuantHealth is already working with several global pharmaceutical companies to use its product in clinical trial design and development. Petra Jantzer, Ph.D., Originally announced January 8th, 2024